Breaking News Instant updates and real-time market news.

ORTX

Orchard Therapeutics

$13.99 /

+1.14 (+8.87%)

, SLDB

Solid Biosciences

$7.17 /

+0.02 (+0.28%)

11:53
02/08/19
02/08
11:53
02/08/19
11:53

Goldman says Orchard track record stands out amid disappointments in gene space

Goldman Sachs analyst Graig Suvannavejh noted that February 7 was "a day of disappointment" in the gene therapy and gene editing space, as Solid Biosciences (SLDB) and Sangamo (SGMO) both reported clinical efficacy data that missed investor expectations and "perhaps also raised concerns about the long-term promise of gene-based approaches." Within this context, he pointed out that he believes Orchard Therapeutics (ORTX) has "the most robust clinical experience in gene therapy, with over 150 patients treated across multiple product candidates and indications." The analyst, who expects new clinical data for Orchard candidates OTL-101 and OTL-102 to be presented later this month to re-affirm his confidence, reiterated his Buy rating and $21 price target on Orchard shares.

ORTX

Orchard Therapeutics

$13.99 /

+1.14 (+8.87%)

SLDB

Solid Biosciences

$7.17 /

+0.02 (+0.28%)

SGMO

Sangamo

$7.89 /

-0.455 (-5.46%)

ORTX Orchard Therapeutics
$13.99 /

+1.14 (+8.87%)

12/17/18 Goldman Sachs
Goldman starts Argenx at Conviction Buy, upgrades Orchard to Buy
12/17/18 Goldman Sachs
Orchard Therapeutics upgraded to Buy from Neutral at Goldman Sachs
11/26/18
On The Fly: Top five analyst initiations
11/26/18 Cowen
Orchard Therapeutics initiated with an Outperform at Cowen
SLDB Solid Biosciences
$7.17 /

+0.02 (+0.28%)

02/08/19 Citi
Citi upgrades Solid Biosciences to Neutral after Sell thesis played out
02/08/19 Citi
Solid Biosciences upgraded to Neutral from Sell at Citi
02/07/19 SVB Leerink
Solid Biosciences downgraded to Market Perform from Outperform at SVB Leerink
02/07/19 Piper Sandler
Piper says Sarepta position strengthened by Solid's 'dismal expression' data
SGMO Sangamo
$7.89 /

-0.455 (-5.46%)

02/08/19 Jefferies
Jefferies sees opportunity in Sangamo after selloff, drops target to $23
02/07/19 Wells Fargo
Wells Fargo says buy Sangamo on today's 'overdone' selloff
02/07/19 Piper Sandler
Crispr Therapeutics sell-off 'unfounded,' Overweight reiterated at Piper Jaffray
11/14/18 JPMorgan
JPMorgan downgrades Sangamo to Neutral on 'growing skepticism'

TODAY'S FREE FLY STORIES

Conference/Events
PetMed Express management to meet virtually with Sidoti » 12:11
08/11/20
08/11
12:11
08/11/20
12:11
PETS

PetMed Express

$32.29 /

-0.06 (-0.19%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PETS PetMed Express
$32.29 /

-0.06 (-0.19%)

PETS PetMed Express
$32.29 /

-0.06 (-0.19%)

04/09/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
03/12/20 Sidoti
PetMed Express upgraded to Buy from Neutral at Sidoti
02/24/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
10/17/19 Craig-Hallum
PetMed Express price target raised to $20 from $15 at Craig-Hallum
PETS PetMed Express
$32.29 /

-0.06 (-0.19%)

PETS PetMed Express
$32.29 /

-0.06 (-0.19%)

Hot Stocks
Bristol-Myers says Health Canada approves Opdivo-Yervoy combo » 12:10
08/11/20
08/11
12:10
08/11/20
12:10
BMY

Bristol-Myers

$63.91 /

+2.09 (+3.38%)

Bristol Myers Squibb…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$63.91 /

+2.09 (+3.38%)

BMY Bristol-Myers
$63.91 /

+2.09 (+3.38%)

08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
07/28/20 Raymond James
Bristol-Myers initiated with an Outperform at Raymond James
BMY Bristol-Myers
$63.91 /

+2.09 (+3.38%)

BMY Bristol-Myers
$63.91 /

+2.09 (+3.38%)

BMY Bristol-Myers
$63.91 /

+2.09 (+3.38%)

BMY Bristol-Myers
$63.91 /

+2.09 (+3.38%)

Hot Stocks
Arbutus Biopharma higher after Moderna discusses patent uncertainty » 12:09
08/11/20
08/11
12:09
08/11/20
12:09
ABUS

Arbutus Biopharma

$3.61 /

-0.04 (-1.10%)

, MRNA

Moderna

$69.85 /

-2.18 (-3.03%)

Moderna (MRNA) said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABUS Arbutus Biopharma
$3.61 /

-0.04 (-1.10%)

MRNA Moderna
$69.85 /

-2.18 (-3.03%)

ABUS Arbutus Biopharma
$3.61 /

-0.04 (-1.10%)

07/27/20 B. Riley FBR
Arbutus Biopharma price target raised to $8 from $6 at B. Riley FBR
07/24/20 Baird
Arbutus Biopharma upside priced in, Baird downgrades to Neutral
07/24/20 Baird
Arbutus Biopharma downgraded to Neutral from Outperform at Baird
05/19/20 Wedbush
Arbutus Biopharma upgraded to Outperform at Wedbush following AB-729 data
MRNA Moderna
$69.85 /

-2.18 (-3.03%)

08/06/20 Barclays
Moderna COVID vaccine still has 'best-in-class potential,' says Barclays
08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
ABUS Arbutus Biopharma
$3.61 /

-0.04 (-1.10%)

MRNA Moderna
$69.85 /

-2.18 (-3.03%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$69.85 /

-2.18 (-3.03%)

ABUS Arbutus Biopharma
$3.61 /

-0.04 (-1.10%)

MRNA Moderna
$69.85 /

-2.18 (-3.03%)

MRNA Moderna
$69.85 /

-2.18 (-3.03%)

Hot Stocks
Linx SA (ADS) trading halted, news pending  12:07
08/11/20
08/11
12:07
08/11/20
12:07
LINX

Linx S.A.

$5.22 /

+0.53 (+11.30%)

 
ShowHide Related Items >><<
LINX Linx S.A.
$5.22 /

+0.53 (+11.30%)

LINX Linx S.A.
$5.22 /

+0.53 (+11.30%)

07/15/20 Itau BBA
Linx S.A. downgraded to Market Perform from Outperform at Itau BBA
06/05/20 JPMorgan
Linx S.A. downgraded to Underweight from Neutral at JPMorgan
06/02/20 Credit Suisse
Linx S.A. downgraded to Neutral from Outperform at Credit Suisse
05/18/20 HSBC
Linx S.A. upgraded to Hold from Reduce at HSBC
Options
Dave & Buster's call volume above normal and directionally bullish » 12:05
08/11/20
08/11
12:05
08/11/20
12:05
PLAY

Dave & Buster's

$16.40 /

+1.36 (+9.04%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLAY Dave & Buster's
$16.40 /

+1.36 (+9.04%)

PLAY Dave & Buster's
$16.40 /

+1.36 (+9.04%)

06/12/20
Fly Intel: Top five analyst upgrades
06/12/20 BMO Capital
Dave & Buster's price target raised to $15 from $13 at BMO Capital
06/12/20
Dave & Buster's upgraded to Buy at SunTrust on growing sales at reopened stores
06/12/20 SunTrust
Dave & Buster's upgraded to Buy from Hold at SunTrust
PLAY Dave & Buster's
$16.40 /

+1.36 (+9.04%)

  • 04
    May
PLAY Dave & Buster's
$16.40 /

+1.36 (+9.04%)

PLAY Dave & Buster's
$16.40 /

+1.36 (+9.04%)

Hot Stocks
BAE Systems announces expansion in Austin, Texas with new campus development » 12:01
08/11/20
08/11
12:01
08/11/20
12:01
BAESY

BAE Systems

$0.00 /

+ (+0.00%)

BAE Systems announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BAESY BAE Systems
$0.00 /

+ (+0.00%)

BAESY BAE Systems
$0.00 /

+ (+0.00%)

08/03/20 Credit Suisse
BAE Systems H1 results upbeat on EBIT, says Credit Suisse
08/03/20 Berenberg
Berenberg backs Buy on BAE Systems
07/31/20 JPMorgan
BAE Systems price target lowered to 750 GBp from 765 GBp at JPMorgan
07/21/20 Exane BNP Paribas
BAE Systems upgraded to Outperform from Neutral at Exane BNP Paribas
BAESY BAE Systems
$0.00 /

+ (+0.00%)

Hot Stocks
Northwest Biotherapeutics completes financing for $8M » 12:01
08/11/20
08/11
12:01
08/11/20
12:01
NWBO

Northwest Biotherapeutics

$0.00 /

+ (+0.00%)

Northwest Biotherapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NWBO Northwest Biotherapeutics
$0.00 /

+ (+0.00%)

Conference/Events
CNS Pharmaceuticals to hold a webinar » 12:01
08/11/20
08/11
12:01
08/11/20
12:01
CNSP

CNS Pharmaceuticals

$1.92 /

+ (+0.00%)

CEO Climaco discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNSP CNS Pharmaceuticals
$1.92 /

+ (+0.00%)

CNSP CNS Pharmaceuticals
$1.92 /

+ (+0.00%)

12/04/19 Benchmark
CNS Pharmaceuticals initiated with a Speculative Buy at Benchmark
  • 08
    Nov
Hot Stocks
PwerShares Dynamic Software rises -0.7% » 12:00
08/11/20
08/11
12:00
08/11/20
12:00
PSJ

PwerShares Dynamic Software

$119.42 /

-0.98 (-0.81%)

PwerShares Dynamic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Large Cap Growth Index-Linked ETN rises 1225.3% » 12:00
08/11/20
08/11
12:00
08/11/20
12:00
FRLG

Large Cap Growth Index-Linked ETN

$182.00 /

+15.6 (+9.38%)

Large Cap Growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRLG Large Cap Growth Index-Linked ETN
$182.00 /

+15.6 (+9.38%)

Hot Stocks
First Trust NYSE Arca Biotechnology rises 0.3% » 12:00
08/11/20
08/11
12:00
08/11/20
12:00
FBT

First Trust NYSE Arca Biotechnology

$165.26 /

+0.81 (+0.49%)

First Trust NYSE Arca…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Moderna uncertain about COVID-19 vaccine patent exclusivity » 11:59
08/11/20
08/11
11:59
08/11/20
11:59
MRNA

Moderna

$70.40 /

-1.63 (-2.26%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$70.40 /

-1.63 (-2.26%)

MRNA Moderna
$70.40 /

-1.63 (-2.26%)

08/06/20 Barclays
Moderna COVID vaccine still has 'best-in-class potential,' says Barclays
08/05/20 Piper Sandler
Piper reiterates $134 target on Moderna, notes Q2 ended with $3.1B cash
08/03/20 Jefferies
Moderna's Phase 3 data on COVID vaccine could come by October, says Jefferies
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
MRNA Moderna
$70.40 /

-1.63 (-2.26%)

  • 19
    May
  • 12
    Feb
MRNA Moderna
$70.40 /

-1.63 (-2.26%)

MRNA Moderna
$70.40 /

-1.63 (-2.26%)

MRNA Moderna
$70.40 /

-1.63 (-2.26%)

Conference/Events
WillScot Mobile Mini management to meet virtually with Oppenheimer » 11:54
08/11/20
08/11
11:54
08/11/20
11:54
WSC

WillScot Mobile Mini

$17.84 /

+0.46 (+2.65%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WSC WillScot Mobile Mini
$17.84 /

+0.46 (+2.65%)

WSC WillScot Mobile Mini
$17.84 /

+0.46 (+2.65%)

07/21/20
Fly Intel: Top five analyst initiations
07/21/20 Morgan Stanley
WillScot Mobile Mini resumed with an Overweight at Morgan Stanley
07/02/20 Deutsche Bank
WillScot resumed with a Buy at Deutsche Bank
07/01/20
Fly Intel: Top five analyst initiations
WSC WillScot Mobile Mini
$17.84 /

+0.46 (+2.65%)

WSC WillScot Mobile Mini
$17.84 /

+0.46 (+2.65%)

Recommendations
Craig-Hallum suspends rating on GTT Communications after filing delay » 11:53
08/11/20
08/11
11:53
08/11/20
11:53
GTT

GTT Communications

$5.07 /

-0.53 (-9.46%)

Craig-Hallum analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GTT GTT Communications
$5.07 /

-0.53 (-9.46%)

GTT GTT Communications
$5.07 /

-0.53 (-9.46%)

07:49 Today Raymond James
GTT Communications downgraded at Raymond James on financial reporting miscue
06:27 Today Raymond James
GTT Communications downgraded to Underperform from Outperform at Raymond James
05/26/20 Raymond James
GTT Communications upgraded to Outperform from Market Perform at Raymond James
05/11/20 SunTrust
GTT Communications downgraded to Hold from Buy at SunTrust
GTT GTT Communications
$5.07 /

-0.53 (-9.46%)

GTT GTT Communications
$5.07 /

-0.53 (-9.46%)

GTT GTT Communications
$5.07 /

-0.53 (-9.46%)

GTT GTT Communications
$5.07 /

-0.53 (-9.46%)

Hot Stocks
Occidental says Algeria assets not for sale » 11:51
08/11/20
08/11
11:51
08/11/20
11:51
OXY

Occidental Petroleum

$16.29 /

-0.18 (-1.09%)

On its Q2 earnings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OXY Occidental Petroleum
$16.29 /

-0.18 (-1.09%)

OXY Occidental Petroleum
$16.29 /

-0.18 (-1.09%)

08/04/20 Credit Suisse
Occidental Petroleum assumed with an Underperform at Credit Suisse
06/23/20 Barclays
Occidental Petroleum price target raised to $21 from $15 at Barclays
06/19/20 SunTrust
Occidental Petroleum upgraded to Buy from Hold at SunTrust
06/19/20 Mizuho
Occidental Petroleum price target raised to $18 from $13 at Mizuho
OXY Occidental Petroleum
$16.29 /

-0.18 (-1.09%)

OXY Occidental Petroleum
$16.29 /

-0.18 (-1.09%)

OXY Occidental Petroleum
$16.29 /

-0.18 (-1.09%)

OXY Occidental Petroleum
$16.29 /

-0.18 (-1.09%)

Conference/Events
Sage Therapeutics management to meet virtual with Oppenheimer » 11:51
08/11/20
08/11
11:51
08/11/20
11:51
SAGE

Sage Therapeutics

$53.13 /

-0.08 (-0.15%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$53.13 /

-0.08 (-0.15%)

SAGE Sage Therapeutics
$53.13 /

-0.08 (-0.15%)

09:32 Today Oppenheimer
Sage Therapeutics price target raised to $65 from $50 at Oppenheimer
08/10/20 Raymond James
Raymond James upgrades Sage Therapeutics on zuranolone, pipeline programs
08/10/20 Raymond James
Sage Therapeutics upgraded to Outperform from Market Perform at Raymond James
07/15/20
Sage Therapeutics participates in a conference all hosted by SunTrust
SAGE Sage Therapeutics
$53.13 /

-0.08 (-0.15%)

Options
MetLife call volume above normal and directionally bullish » 11:45
08/11/20
08/11
11:45
08/11/20
11:45
MET

MetLife

$40.65 /

+0.885 (+2.23%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MET MetLife
$40.65 /

+0.885 (+2.23%)

MET MetLife
$40.65 /

+0.885 (+2.23%)

06/01/20 BofA
MetLife reinstated with a Buy at BofA
05/13/20 JPMorgan
MetLife comments at forum 'fairly positive,' says JPMorgan
05/07/20 JPMorgan
MetLife down as much as sector, which is unwarranted, says JPMorgan
04/27/20 Credit Suisse
MetLife price target lowered to $46 from $60 at Credit Suisse
MET MetLife
$40.65 /

+0.885 (+2.23%)

MET MetLife
$40.65 /

+0.885 (+2.23%)

MET MetLife
$40.65 /

+0.885 (+2.23%)

General news
San Francisco Federal Reserve Bank President Mary Daly Speech to be released at 12:00  11:45
08/11/20
08/11
11:45
08/11/20
11:45
 
Recommendations
Rightmove price target raised to 520 GBp from 440 GBp at RBC Capital » 11:43
08/11/20
08/11
11:43
08/11/20
11:43
RTMVY

Rightmove

$0.00 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RTMVY Rightmove
$0.00 /

+ (+0.00%)

08/10/20 Credit Suisse
Rightmove price target raised to 570 GBp from 560 GBp at Credit Suisse
07/10/20 UBS
Rightmove price target raised to 545 GBp from 500 GBp at UBS
07/07/20 Barclays
Rightmove price target raised to 450 GBp from 400 GBp at Barclays
07/07/20 Investec
Rightmove downgraded to Sell from Hold at Investec
Recommendations
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler » 11:43
08/11/20
08/11
11:43
08/11/20
11:43
MDT

Medtronic

$101.90 /

+1.5 (+1.49%)

, PODD

Insulet

$202.32 /

-1.67 (-0.82%)

, TNDM

TNDM

/

+

, DXCM

DexCom

$417.18 /

-4.13 (-0.98%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDT Medtronic
$101.90 /

+1.5 (+1.49%)

PODD Insulet
$202.32 /

-1.67 (-0.82%)

TNDM TNDM
/

+

DXCM DexCom
$417.18 /

-4.13 (-0.98%)

MDT Medtronic
$101.90 /

+1.5 (+1.49%)

08/03/20 Piper Sandler
Piper says Axonics positioned for continued share taking despite Medtronic nod
07/27/20 Piper Sandler
Axonics data 'strong and consistent' with one-year results, says Piper Sandler
07/17/20 B. Riley FBR
B. Riley FBR starts ClearPoint at Buy, sees potential takeover
07/16/20 Goldman Sachs
J&J delay to robotic surgery program a positive for Intuitive, says Goldman
PODD Insulet
$202.32 /

-1.67 (-0.82%)

08/07/20 Stephens
Insulet price target raised to $230 from $165 at Stephens
08/07/20 Citi
Insulet price target raised to $255 from $200 at Citi
08/06/20 Piper Sandler
Insulet price target raised to $260 from $235 at Piper Sandler
07/28/20
Fly Intel: Top five analyst initiations
TNDM TNDM
/

+

07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
07/31/20 Lake Street
Tandem Diabetes price target raised to $137 from $125 at Lake Street
07/31/20 Guggenheim
Guggenheim upgrades Tandem Diabetes to Buy, says tailwinds not fully baked in
07/31/20 Guggenheim
Tandem Diabetes upgraded to Buy from Neutral at Guggenheim
DXCM DexCom
$417.18 /

-4.13 (-0.98%)

07/29/20 SVB Leerink
DexCom price target raised to $485 from $465 at SVB Leerink
07/29/20 Guggenheim
DexCom price target raised to $500 from $395 at Guggenheim
07/29/20 Canaccord
DexCom price target raised to $500 from $435 at Canaccord
07/29/20 Raymond James
DexCom price target raised to $450 from $395 at Raymond James
MDT Medtronic
$101.90 /

+1.5 (+1.49%)

PODD Insulet
$202.32 /

-1.67 (-0.82%)

TNDM TNDM
/

+

DXCM DexCom
$417.18 /

-4.13 (-0.98%)

  • 13
    May
MDT Medtronic
$101.90 /

+1.5 (+1.49%)

DXCM DexCom
$417.18 /

-4.13 (-0.98%)

MDT Medtronic
$101.90 /

+1.5 (+1.49%)

PODD Insulet
$202.32 /

-1.67 (-0.82%)

TNDM TNDM
/

+

DXCM DexCom
$417.18 /

-4.13 (-0.98%)

MDT Medtronic
$101.90 /

+1.5 (+1.49%)

Recommendations
Teranga Gold price target raised to C$20 from C$13 at RBC Capital » 11:43
08/11/20
08/11
11:43
08/11/20
11:43
TGCDF

Teranga Gold

$0.00 /

+ (+0.00%)

RBC Capital analyst Wayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGCDF Teranga Gold
$0.00 /

+ (+0.00%)

08/07/20 Stifel
Teranga Gold price target raised to C$20 from C$18 at Stifel
07/28/20 Raymond James
Teranga Gold price target raised to C$19.50 from C$17.25 at Raymond James
07/28/20 CIBC
Teranga Gold price target raised to C$19 from C$18 at CIBC
07/28/20 National Bank
Teranga Gold upgraded to Outperform from Sector Perform at National Bank
Periodicals
Apple signs first-look TV, film deal with Martin Scorsese, Deadline reports » 11:42
08/11/20
08/11
11:42
08/11/20
11:42
AAPL

Apple

$448.37 /

-2.59 (-0.57%)

Apple has signed a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$448.37 /

-2.59 (-0.57%)

AAPL Apple
$448.37 /

-2.59 (-0.57%)

08/10/20 Deutsche Bank
Apple price target raised to $480 from $440 at Deutsche Bank
08/10/20 Wedbush
Apple price target raised to $515 from $475 at Wedbush
08/10/20 KeyBanc
Survey indicates strengthening recovery in Apple iPhone sales, says KeyBanc
08/06/20 KeyBanc
Synaptics upgraded to Overweight from Sector Weight at KeyBanc
AAPL Apple
$448.37 /

-2.59 (-0.57%)

AAPL Apple
$448.37 /

-2.59 (-0.57%)

AAPL Apple
$448.37 /

-2.59 (-0.57%)

AAPL Apple
$448.37 /

-2.59 (-0.57%)

AAPL Apple
$448.37 /

-2.59 (-0.57%)

Recommendations
Alimentation Couche-Tard price target raised to C$51 from C$49 at RBC Capital » 11:42
08/11/20
08/11
11:42
08/11/20
11:42
ANCUF

Alimentation Couche-Tard

$0.00 /

+ (+0.00%)

RBC Capital analyst Irene…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

07/13/20 BMO Capital
BMO backs Outperform on Alimentation Couche-Tard after store sale reports
07/02/20 Scotiabank
Alimentation Couche-Tard price target raised to C$51 from C$44
07/02/20 TD Securities
Alimentation Couche-Tard price target raised to C$50 from C$49 at TD Securities
07/02/20 CIBC
Alimentation Couche-Tard price target raised to C$49 from C$46
ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

ANCUF Alimentation Couche-Tard
$0.00 /

+ (+0.00%)

Recommendations
Canopy Growth price target raised to C$22 from C$21 at Canaccord » 11:40
08/11/20
08/11
11:40
08/11/20
11:40
CGC

Canopy Growth

$17.67 /

-0.26 (-1.45%)

Canaccord analyst Matt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGC Canopy Growth
$17.67 /

-0.26 (-1.45%)

CGC Canopy Growth
$17.67 /

-0.26 (-1.45%)

07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
06/24/20 Cantor Fitzgerald
Aurora Cannabis price target raised to C$29 from C$27 at Cantor Fitzgerald
06/01/20 Canaccord
Canopy Growth price target lowered to C$21 from C$23 at Canaccord
06/01/20 Scotiabank
Canopy Growth price target lowered to C$28 from C$33 at Scotiabank
CGC Canopy Growth
$17.67 /

-0.26 (-1.45%)

CGC Canopy Growth
$17.67 /

-0.26 (-1.45%)

CGC Canopy Growth
$17.67 /

-0.26 (-1.45%)

CGC Canopy Growth
$17.67 /

-0.26 (-1.45%)

Recommendations
Neo Performance Materials price target raised to C$11 from C$10 at Canaccord » 11:39
08/11/20
08/11
11:39
08/11/20
11:39
NOPMF

Neo Performance Materials

$0.00 /

+ (+0.00%)

Canaccord analyst Yuri…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOPMF Neo Performance Materials
$0.00 /

+ (+0.00%)

11:20 Today Scotiabank
Neo Performance Materials price target lowered to C$12 from C$13 at Scotiabank
05/15/20 CIBC
Neo Performance Materials price target lowered to C$9 from C$11 at CIBC
05/14/20 CIBC
Neo Performance downgraded to Neutral from Outperformer at CIBC
05/08/20 RBC Capital
Neo Performance Materials price target lowered to C$11 from C$12 at RBC Capital

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.